09:00 – 10:00 |
Wolfson
Theatre |
|
|
Plenary lecture: Society for Endocrinology
Medal Lecture |
|
|
Chair: Bloom S (London) |
| |
|
|
| S3 |
09:00 |
Oestrogen and the skeleton |
| |
|
Eastell R (Sheffield) |
|
|
|
10:00 – 10:30 |
Osler/Long Room |
|
|
Coffee |
|
|
|
10:30 – 12:30 |
Wolfson Theatre |
|
|
Symposium 3: Hormones in natural products |
|
|
Chair: Henderson I (Sheffield) |
| |
|
|
S13 |
10:30 |
Hormones
in natural products - an overview |
|
|
Ashby J (Macclesfield) |
|
|
|
S14 |
11:00 |
Natural
endocrine disrupters in aquatic environments |
|
|
Sumpter J (Uxbridge) |
|
|
|
S15 |
11:30 |
Gender dysfunction in newborn males |
|
|
Hughes I (Cambridge) |
|
|
|
S16 |
12:00 |
Phytoestrogens
- beyond the oestrogen receptor |
|
|
Whitehead S (London) |
|
|
|
10:30 – 12:30 |
Seligman
Theatre |
|
|
Nurses Session |
|
|
Neuroendocrine tumours - an update
GENEROUSLY SUPPORTED BY NOVARTIS PHARMACEUTICALS UK LTD |
|
|
Chairs: Coskeran P (London) & Gagen C (London) |
| |
|
|
S21 |
10:30 |
Introduction to NET: Definition, classification and diagnosis |
|
|
Caplin M (London) |
|
|
|
S22 |
11:00 |
The role of the nurse specialist in the co-ordination of patient care |
|
|
Bouvier C (London) & Thatcher J (London) |
|
|
|
S23 |
11:30 |
Injection
techniques - getting it right |
|
|
King B (Basingstoke) |
|
|
|
S24 |
12:00 |
A case
of MEN 1 syndrome with secretion of multiple gut hormones |
|
|
Gibson C (Manchester) |
|
|
|
12:30 – 13:30 |
Library |
|
|
Attended Posters |
|
|
|
12:30 – 14:30 |
Osler/Long Room |
|
|
Lunch |
|
|
|
13:30 – 14:30 |
Wolfson
Theatre |
|
|
Clinical
Endocrine Debate: |
|
|
This house believes that bilateral adrenalectomy
is the treatment of choice for Cushing’s disease |
|
|
Chair: Atkinson B (Belfast) |
|
|
|
|
|
Proposer - Newell-Price J (Sheffield) |
|
|
Opposer - Scanlon M (Cardiff) |
|
|
|
14:15 – 16:30 |
Seligman Theatre |
|
|
Basic Science Review Lecture |
|
|
Young Endocrinologists Session |
|
|
Chairs: Fowkes R (London) & Bloom S (London) |
|
|
|
|
|
Basic Science Review Lecture |
S4 |
14:15 |
Understanding
endocrine development of the human beta cell: guiding stem cell therapy
for Type 1 Diabetes |
|
|
Piper K (Southampton) |
|
|
|
|
|
Oral Communications 3: Young Endocrinologists Session |
|
|
|
OC18 |
14:45 |
Regulation
of canonical Wnt/beta-catenin signalling pathway plays a central role in
thyroid growth and proliferation in neoplastic
thyroid cell lines |
|
|
Rao AS, Kremenevskaja N, Resch J & Brabant G |
|
|
|
OC19 |
15:00 |
Proliferative
effects of ghrelin and desoctanoyl ghrelin are independent of the growth
hormone secretagogue receptor
(GHS-R) |
|
|
Marsh VB, Kola B, Hanson M, Emery M, Musat M, Bonner S, Khalaf S, Norman D, Grossman AB & Korbonits M |
|
|
|
*OC20 |
15:15 |
Sp1/Sp3, GnRH
and PACAP involvement in C-type natriuretic peptide (CNP/Nppc) expression
and action in gonadotrophs |
|
|
Fowkes RC, Burrin JM, McArdle CA & Steinhelper ME |
|
|
|
*OC21 |
15:30 |
Failure
of suppression of endogenous glucose production (EGP) diminished lipolysis
and free fatty acid (FFA) oxidation in
a population at high risk of the development of Type 2 diabetes |
|
|
Forbes S, Robinson S, McCarthy MI, MacDonald IA, Bannister
P, Venketesan S & Johnston DG |
|
|
|
*OC22 |
15:45 |
Effect
of variation at the aldosterone synthase locus (CYP11B2) on adrenal
11-beta hydroxylation: pilot data from the MRC BRIGHT
study |
|
|
Freel M, McKenzie S, Friel E, Ingram M, Davies E, Fraser
R, Dominiczak A, Caulfield M & Connell J |
|
|
|
*OC23 |
16:00 |
Adrenal
and circulating agouti related protein (AgRP) is upregulated in Cushing's
syndrome suggesting a novel inhibitory
paracrine role in the human adrenal gland |
|
|
Dhillo WS, Castle L, Gardiner JV, Bewick GA, Smith KL, Meeran
K, Todd JF, Ghatei MA & Bloom SR |
|
|
|
*OC24 |
16:15 |
A
pilot study of prolonged high dose rosiglitazone therapy (12mg/day)
in Nelson's syndrome |
|
|
Munir A, Song F, Ince P, Ross R & Newell-Price J |
|
|
|
14.30 – 16.30 |
Wolfson Theatre |
|
|
Symposium 4: Consequences of a lack of androgens |
|
|
Chair: Randall V (Bradford) |
|
|
|
S17 |
14:30 |
Androgen
action and the male adult phenotype from youth to senescence |
|
|
Nieschlag E (Münster, Germany) |
|
|
|
S18 |
15:00 |
Consequences
of androgen receptor abnormalities |
|
|
Hiort O (Lübeck, Germany) |
|
|
|
S19 |
15:30 |
SARMS
(Selective Androgen Receptor Modulators) |
|
|
Grootenhuis A (Oss, The Netherlands) |
|
|
|
S20 |
16:00 |
Hormonal male contraception: an update |
|
|
Wu F (Manchester) |
|
|
|
16:30 – 16:45 |
Osler Room |
|
|
Tea |
|
|
|
16:45– 17:45 |
Seligman Theatre |
|
|
Eli Lilly & Company Ltd Satellite |
|
|
The Hypopituitary Control and Complication Study |
|
|
|